Clinical trial
CHAMPION-AF Clinical Trial
NCT04394546 · Boston Scientific Corporation, Industry · Active, not recruiting
Key facts
| NCT number | NCT04394546 |
|---|---|
| Title | CHAMPION-AF Clinical Trial |
| Official title | WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation |
| Acronym | CHAMPION-AF |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Stroke, Bleeding |
| Intervention type | Device, Drug |
| Interventions | WATCHMAN FLX LAAC Device, Non-Vitamin K Oral Anticoagulant |
| Enrollment | 3,000 |
| Start date | Oct 15, 2020 |
| Primary completion | Dec 1, 2027 |
| Completion | Dec 1, 2027 |
| First posted | May 19, 2020 |
| Last update posted | Jan 13, 2026 |
| Countries | Australia, Belgium, Canada, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Saudi Arabia and 4 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: